News
DSNKY
17.18
+1.54%
0.26
Weekly Report: what happened at DSNKY last week (0720-0724)?
Weekly Report · 2h ago
J&J, Gilead among recipients of EU drug recommendations this week
Seeking Alpha · 2d ago
Weekly Report: what happened at DSNKY last week (0713-0717)?
Weekly Report · 07/20 09:19
Nvidia CEO Huang visits Japan, unveils AI partnerships across key industries
Seeking Alpha · 07/16 04:52
Weekly Report: what happened at DSNKY last week (0706-0710)?
Weekly Report · 07/13 09:19
Astra, Daiichi said to be nearing U.K. drug pricing deal for breast cancer drug, Enhertu
Seeking Alpha · 07/08 12:01
'AstraZeneca, Daiichi Near UK Price Deal for Breast Cancer Drug' - Bloomberg
Benzinga · 07/08 11:36
My Top 5 Pharma Stocks Wall Street Ignores
Seeking Alpha · 07/06 13:55
Weekly Report: what happened at DSNKY last week (0629-0703)?
Weekly Report · 07/06 09:20
Daiichi Sankyo: Not Exciting Enough For This Market, Apparently
Seeking Alpha · 07/01 16:02
Weekly Report: what happened at DSNKY last week (0622-0626)?
Weekly Report · 06/29 09:19
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Seeking Alpha · 06/26 13:22
EU CHMP Recommends Approval Of Daiichi Sankyo and AstraZeneca's Datroway For First-Line Treatment Of Adult Patients With Unresectable Or Metastatic Triple Negative Breast Cancer
Benzinga · 06/26 11:17
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The Wall Street Journal · 06/24 19:42
Weekly Report: what happened at DSNKY last week (0615-0619)?
Weekly Report · 06/22 09:22
Weekly Report: what happened at DSNKY last week (0608-0612)?
Weekly Report · 06/15 09:22
Tencent Music, CSL among global large caps with persistent bearish Quant signals
Seeking Alpha · 06/10 13:19
Weekly Report: what happened at DSNKY last week (0601-0605)?
Weekly Report · 06/08 09:21
Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise
Seeking Alpha · 06/05 16:25
Weekly Report: what happened at DSNKY last week (0525-0529)?
Weekly Report · 06/01 09:22
More
Webull provides a variety of real-time DSNKY stock news. You can receive the latest news about Daiichi Sankyo through multiple platforms. This information may help you make smarter investment decisions.
About DSNKY
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.